Intuitive Surgical 미래 성장

Future 기준 확인 3/6

Intuitive Surgical (는) 각각 연간 11.5% 및 13.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 11.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.3% 로 예상됩니다.

주요 정보

11.5%

수익 성장률

11.2%

EPS 성장률

Medical Equipment 수익 성장	0%
매출 성장률	13.4%
향후 자기자본 수익률	14.3%
애널리스트 커버리지	Good
마지막 업데이트	15 Nov 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

BMV:ISRG * - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	10,980	2,842	3,727	4,335	25
12/31/2025	9,515	2,524	2,735	3,637	29
12/31/2024	8,141	2,165	2,066	3,285	29
9/30/2024	7,867	2,243	586	1,821	N/A
6/30/2024	7,573	2,094	420	1,663	N/A
3/31/2024	7,319	1,988	596	1,708	N/A
12/31/2023	7,124	1,798	750	1,814	N/A
9/30/2023	6,851	1,517	1,256	2,023	N/A
6/30/2023	6,665	1,425	1,178	1,858	N/A
3/31/2023	6,431	1,312	1,006	1,639	N/A
12/31/2022	6,222	1,322	958	1,491	N/A
9/30/2022	6,118	1,378	1,091	1,621	N/A
6/30/2022	5,964	1,435	1,310	1,739	N/A
3/31/2022	5,906	1,644	1,460	1,835	N/A
12/31/2021	5,710	1,705	1,750	2,089	N/A
9/30/2021	5,489	1,689	1,885	2,149	N/A
6/30/2021	5,163	1,623	1,662	1,922	N/A
3/31/2021	4,551	1,173	1,315	1,610	N/A
12/31/2020	4,358	1,061	1,143	1,485	N/A
9/30/2020	4,307	1,053	988	1,410	N/A
6/30/2020	4,358	1,136	1,088	1,532	N/A
3/31/2020	4,604	1,386	1,202	1,618	N/A
12/31/2019	4,479	1,379	1,173	1,598	N/A
9/30/2019	4,247	1,314	1,045	1,384	N/A
6/30/2019	4,040	1,210	1,008	1,307	N/A
3/31/2019	3,850	1,147	961	1,223	N/A
12/31/2018	3,724	1,128	982	1,170	N/A
9/30/2018	3,570	804	1,001	1,164	N/A
6/30/2018	3,457	810	N/A	1,198	N/A
3/31/2018	3,306	778	N/A	1,183	N/A
12/31/2017	3,138	671	N/A	1,144	N/A
9/30/2017	3,003	906	N/A	1,142	N/A
6/30/2017	2,878	819	N/A	1,057	N/A
3/31/2017	2,790	780	N/A	1,102	N/A
12/31/2016	2,707	738	N/A	1,087	N/A
9/30/2016	2,619	722	N/A	1,041	N/A
6/30/2016	2,522	678	N/A	952	N/A
3/31/2016	2,434	628	N/A	875	N/A
12/31/2015	2,367	589	N/A	806	N/A
9/30/2015	2,285	546	N/A	683	N/A
6/30/2015	2,250	502	N/A	654	N/A
3/31/2015	2,179	472	N/A	623	N/A
12/31/2014	2,132	419	N/A	665	N/A
9/30/2014	2,082	438	N/A	700	N/A
6/30/2014	2,031	471	N/A	753	N/A
3/31/2014	2,097	526	N/A	788	N/A
12/31/2013	2,244	671	N/A	880	N/A

애널리스트 미래 성장 예측

수입 대 저축률: ISRG * 의 연간 예상 수익 증가율( 11.5% )이 saving rate( 8.1% 보다 높습니다. ).

수익 vs 시장: ISRG * 의 연간 수익( 11.5% ) MX 시장( 11.5% 보다 빠르게 성장할 것으로 예상됩니다. 11.5% 연간).

고성장 수익: ISRG * 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: ISRG * 의 수익(연간 13.4% ) MX 시장( 7.2% 보다 빠르게 성장할 것으로 예상됩니다. 7.2% 연간).

고성장 수익: ISRG * 의 수익(연간 13.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ISRG * 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 14.3 %).

Intuitive Surgical 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Recent updates

Third quarter 2024 earnings released: EPS: US$1.59 (vs US$1.18 in 3Q 2023)

Intuitive Appoints David J. Rosa as Board of Directors

Second quarter 2024 earnings released: EPS: US$1.48 (vs US$1.20 in 2Q 2023)

Investor sentiment improves as stock rises 18%

Intuitive Surgical, Inc. Announces FDA Clearance of Revised Da Vinci Xi and X Labeling on Radical Prostatectomy

Intuitive Elects Lewis Chew as Board of Directors

First quarter 2024 earnings released: EPS: US$1.54 (vs US$1.02 in 1Q 2023)

Intuitive Surgical, Inc., Annual General Meeting, Apr 25, 2024

Intuitive Surgical, Inc. Announces FDA Clearance of Fifth-Generation Robotic System, Da Vinci 5

Full year 2023 earnings released: EPS: US$5.12 (vs US$3.72 in FY 2022)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

New major risk - Share price stability

Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors

Third quarter 2023 earnings released: EPS: US$1.18 (vs US$0.91 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.20 (vs US$0.86 in 2Q 2022)

Intuitive Surgical, Inc.(NasdaqGS:ISRG) dropped from Russell 1000 Value Index

Intuitive Surgical, Inc. Announces Executive Changes

Insufficient new directors

First quarter 2023 earnings released: EPS: US$1.02 (vs US$1.02 in 1Q 2022)

Full year 2022 earnings released: EPS: US$3.72 (vs US$4.79 in FY 2021)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Third quarter 2022 earnings released: EPS: US$0.91 (vs US$1.07 in 3Q 2021)

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$1.45 in 2Q 2021)

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

Intuitive Surgical, Inc., Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Intuitive Receives FDA Clearance for 8 mm SureForm 30 Curved-Tip Stapler

Third quarter 2021 earnings released: EPS US$2.17 (vs US$0.89 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$4.36 (vs US$0.58 in 2Q 2020)

First quarter 2021 earnings released: EPS US$3.61 (vs US$2.69 in 1Q 2020)

Revenue beats expectations

Full year 2020 earnings released: EPS US$9.07 (vs US$11.95 in FY 2019)

Revenue beats expectations

Full year 2020 earnings released: EPS US$9.07

Intuitive Surgical, Inc. to Report Q4, 2020 Results on Jan 21, 2021

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견